All Stories

  1. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference
  2. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
  3. Anatomical limits in living donor liver transplantation
  4. The role of the graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations
  5. Verifying the Benefits of Radical Treatment in Posttransplant Hepatocellular Carcinoma Oligo‐recurrence: A Propensity Score Analysis
  6. Immunotherapy after liver transplantation: Where are we now?
  7. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
  8. Critical appraisal of TNM versus HKU staging system for postoperative prognostic evaluation of hepatocellular carcinoma
  9. Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
  10. Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma—a cost-effectiveness analysis
  11. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma
  12. Indocyanine green fluorescence-assisted laparoscopic hepatectomy for hepatocellular carcinoma in a pre-adolescent girl: a case report
  13. Transferability of Liver Transplantation Experience to Complex Liver Resection for Locally Advanced Hepatobiliary Malignancy – Lessons Learnt From 3 Decades of Single Center Experience
  14. Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation
  15. Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
  16. The Risk of Going Small
  17. HBV‐ TERT Promoter Integration Harnesses Host ELF4 Resulting in TERT Gene Transcription in Hepatocellular Carcinoma
  18. Expanding Indications for Liver Transplant: Tumor and Patient Factors
  19. Model for End‐stage Liver Disease with additional criteria to predict short‐term mortality in severe flares of chronic hepatitis B
  20. Determining the optimal timing of liver transplant for pediatric patients after Kasai portoenterostomy based on disease severity scores
  21. Impact of Graft Steatosis on Long-Term Graft Survival in Liver Transplantation
  22. Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis
  23. Survival analysis of breast cancer liver metastasis treated by hepatectomy: A propensity score analysis for Chinese women in Hong Kong
  24. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
  25. Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
  26. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma
  27. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong
  28. Feasibility of next-generation sequencing of circulating tumor cells for predicting relapse after liver resection in metastatic colorectal cancer
  29. Donor ductal anomaly is not a contraindication to right liver lobe donation
  30. Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
  31. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma
  32. Prospective Study on Sexual Dysfunction in Male Chinese Liver Transplant Recipients
  33. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
  34. Colorectal liver metastases: An update on multidisciplinary approach
  35. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses
  36. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma
  37. Hepatectomy bridges to transplant—the road to cure?
  38. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report
  39. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy
  40. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
  41. Emergency ABO-incompatible living donor liver transplant for patients with ultrahigh MELD scores
  42. A vena caval mass: challenging diagnosis with a rare complication
  43. What Can We Learn from Living Donor Evaluation? A Higher Prevalence of Metabolic Disease and Less Technical Contraindication
  44. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis
  45. Minimally invasive donor hepatectomy, are we ready for prime time?
  46. Partial portal vein arterialization using right gastroepiploic artery: A novel solution for portal hypoperfusion
  47. Recurrent pyogenic cholangitis – an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma
  48. Hepatitis B vaccination in patients receiving oral antiviral therapy without hepatitis B immune globulin after liver transplantation
  49. Risk Factors for Graft Steatosis after Liver Transplantation using Controlled Attenuation Parameter Measurements
  50. Excellent Perioperative and Long-Term Outcomes with Lower Graft-to-Recipient Weight Ratio for Living Donor Liver Transplantation
  51. Prospective Trial on Sexual Dysfunction in Male Chinese Liver Transplant Recipients
  52. Validated Nomogram for Prediction of Recurrence in HCC within Milan Criteria
  53. Anterior Approach to Major Resection for Colorectal Liver Metastasis
  54. Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial
  55. Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: A propensity analysis at a single center
  56. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation
  57. Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong
  58. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
  59. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis
  60. Asia's first combined liver transplant and aortic valve replacement
  61. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection – A 13-year cohort in a tertiary center
  62. Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases
  63. Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
  64. Risk prediction model for major complication after hepatectomy for malignant tumour - A validated scoring system from a university center
  65. Laparoscopic liver resection versus percutaneous radiofrequency ablation in patients with hepatocellular carcinoma and liver cirrhosis: a case-matched study
  66. The role of oral antiviral therapy in hepatitis B-related hepatocellular carcinoma
  67. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
  68. Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation
  69. Outcome of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs Portal Vein Embolisation (PVE) for Hepatocellular Carcinoma
  70. Is Laparoscopic Major Hepatectomy Superior to Open Major Hepatectomy for Liver Cancer? A Matched Case-Control Study
  71. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation
  72. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer
  73. Role of hepatic trisectionectomy in advanced hepatocellular carcinoma
  74. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway
  75. Surgical strategy for huge and advanced hepatocellular carcinoma in Hong Kong
  76. Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy
  77. Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years
  78. A new formula for estimation of standard liver volume using computed tomography-measured body thickness
  79. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis
  80. Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma – an immunohistochemical study
  81. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience
  82. Liver allograft biopsies with histological cholestasis: a clinicopathological study of 254 cases from a single centre
  83. Combined cavo-atrial thrombectomy and hepatectomy in hepatocellular carcinoma
  84. Acute hepatitis E virus infection causing acute liver failure requiring living-donor liver transplantation in a non-pregnant immunocompetent woman
  85. The role of radiofrequency ablation to liver transection surface in patients with close tumor margin of HCC during hepatectomy—a case matched study
  86. Updates on hepatorenal syndrome and strategies bridging to liver transplantation
  87. Late recurrence of hepatocellular carcinoma after liver transplantation
  88. Importance of Surgical Resection Margin in Colorectal Liver Metastases
  89. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
  90. Survival outcomes of hepatocellular carcinoma resection with postoperative complications – a propensity-score-matched analysis
  91. Liver transplantation: a life-saving procedure following amatoxin mushroom poisoning
  92. Lipid profiles of donors and recipients of liver transplant: like father like son
  93. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS
  94. Resection of T4 hepatocellular carcinomas with adjacent structures, is it justified?
  95. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area
  96. Importance of surgical margin in the outcomes of hepatocholangiocarcinoma
  97. Outcomes of right-lobe and left-lobe living-donor liver transplantations using small-for-size grafts
  98. No increase in graft fibrosis for hepatitis B surface antigen positive patients after liver transplantation using entecavir monotherapy
  99. Systematic review and meta-analysis of studies of biliary reconstruction in adult living donor liver transplantation
  100. An extra-adrenal pheochromocytoma mimicking a primary liver cancer
  101. Impact of intraoperative blood transfusion on long-term outcomes of liver transplantation for hepatocellular carcinoma
  102. Short- and long-term impact of reoperation for complications after major hepatectomy for hepatocellular carcinoma
  103. Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis
  104. New insights after the first 1000 liver transplantations at The University of Hong Kong
  105. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis
  106. Hepatobiliary and Pancreatic: Hepatic splenosis: a rare differential of a liver mass in an HBV endemic area
  107. The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma
  108. Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?
  109. Simultaneous implantation of bilateral liver grafts in living donor liver transplantation with fusion venoplasty
  110. Biliary complications in right lobe living donor liver transplantation
  111. Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy
  112. A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation
  113. Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases
  114. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors
  115. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis
  116. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016
  117. Outcomes of endo-radiological approach to management of bile leakage after right lobe living donor liver transplantation
  118. Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone
  119. Durability of small-for-size living donor allografts
  120. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis
  121. Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience
  122. Liver Resection for De Novo Hepatocellular Carcinoma Complicated by Pyogenic Liver Abscess: A Clinical Challenge
  123. Clinical factors affecting rejection rates in liver transplantation
  124. Rare cause of jaundice in a post liver transplant patient
  125. Comparison of Survival Outcomes Between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience
  126. The friendly incidental portal vein thrombus in liver transplantation
  127. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus
  128. Transplantation of a 2-year-old deceased-donor liver to a 61-year-old male recipient
  129. P0590 : Modified model for end stage liver disease score accurately predicts death or liver transplantation in acute flares of chronic hepatitis B
  130. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5–8 cm
  131. Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation.
  132. Resection of hepatocellular carcinoma after combined treatment with transarterial chemoembolization and sorafenib: a case report and literature review
  133. Management of recurrent hepatocellular carcinoma after liver transplant
  134. Combined sarcomatoid hepatocellular and cholangiocarcinoma: a case report and literature review
  135. Strategies to increase the resectability of hepatocellular carcinoma
  136. Prevention and management of biliary anastomotic stricture in right-lobe living-donor liver transplantation
  137. Retrospective study of metachronous lung metastases from primary hepatocellular carcinoma
  138. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8cm in diameter
  139. Correction: Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
  140. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection?
  141. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation
  142. Treatment Strategy to Improve Long-Term Survival for Hepatocellular Carcinoma Smaller than 5 cm: Major Hepatectomy vs Minor Hepatectomy
  143. Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single-center experience
  144. Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
  145. Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation
  146. A Retrospective Study on Risk Factors Associated With Failed Endoscopic Treatment of Biliary Anastomotic Stricture After Right-Lobe Living Donor Liver Transplantation With Duct-to-Duct Anastomosis
  147. Retransplantation using living-donor right-liver grafts
  148. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas
  149. Samaritan donor interchange in living donor liver transplantation
  150. Technical Tips and Tricks for Living Donations
  151. Low-Volume Deceased Donor Liver Transplantation Alongside a Strong Living Donor Liver Transplantation Service
  152. Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases
  153. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability
  154. Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma
  155. Wait and Transplant for Stage 2 Hepatocellular Carcinoma With Deceased-Donor Liver Grafts
  156. Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
  157. Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma
  158. Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome
  159. Difference in cardiac manifestation between liver transplantation candidates with alcoholic and hepatitis related cirrhosis
  160. Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma
  161. Outcomes of central bisectionectomy for hepatocellular carcinoma
  162. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study
  163. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour
  164. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores
  165. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
  166. Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
  167. Improvising hepatic venous outflow and inferior vena cava reconstruction for combined heart and liver and sequential liver transplantations
  168. Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma
  169. Treatment strategy for recurrent hepatocellular carcinoma: Salvage transplantation, repeated resection, or radiofrequency ablation?
  170. Long-Term Survival Analysis of Pure Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis
  171. Outcomes of side-to-side conversion hepaticojejunostomy for biliary anastomotic stricture after right-liver living donor liver transplantation
  172. 11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective
  173. Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma
  174. High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients
  175. Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy
  176. Remnant left liver size and recovery of living right liver donors
  177. Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West
  178. Evaluation of Survival after Primary Liver Transplantation for Hepatocellular Carcinoma Within UCSF Criteria
  179. Increasing the Recipient-Benefit to Donor-Risk Ratio by Lowering the Graft Size Requirement for Living Donor Liver Transplantation
  180. Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases
  181. High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation
  182. Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis
  183. Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation
  184. Bile duct anastomotic stricture after pediatric living donor liver transplantation
  185. Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation
  186. Tolerance of High-Intensity Focused Ultrasound Ablation in Patients with Hepatocellular Carcinoma
  187. Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma
  188. The impact of family history of hepatocellular carcinoma on its patients' survival
  189. 147 HCC RECURRENCE AFTER LIVER TRANSPLANTATION IN ASIA VS. EUROPE: WHICH IS THE DIFFERENCE?
  190. Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients
  191. Re-resection for metachronous primary hepatocellular carcinoma: is it justified?
  192. Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation
  193. Effects of the liver volume and donor steatosis on errors in the estimated standard liver volume
  194. Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
  195. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion
  196. Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
  197. Can positron emission tomography with the dual tracers [11C]acetate and [18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
  198. Emergency re-routing of anterior sector venous outflow for right lobe living donor liver transplantation including the middle hepatic vein
  199. Impact of Antiviral Therapy on the Survival of Patients After Major Hepatectomy for Hepatitis B Virus–Related Hepatocellular Carcinoma
  200. Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
  201. High-Intensity Focused Ultrasound for Hepatocellular Carcinoma
  202. Validation of graft and standard liver size predictions in right liver living donor liver transplantation
  203. Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation
  204. Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis
  205. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes
  206. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization
  207. Radiofrequency ablation for controlling iatrogenic splenic injury
  208. Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
  209. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience
  210. An Update on Long-Term Outcome of Curative Hepatic Resection for Hepatocholangiocarcinoma
  211. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma
  212. Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population
  213. Safety and Efficacy of Radiofrequency Ablation for Periductal Hepatocellular Carcinoma with Intraductal Cooling of the Central Bile Duct
  214. Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma
  215. Efficacy and tolerability of single agent sorafenib in poor risk advanced hepatocellular carcinoma patients
  216. Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic Factors
  217. Long-term survival after resection of extrahepatic recurrence of hepatocellular carcinoma at the right colon
  218. FACTORS AFFECTING FALSE-NEGATIVE BREAST SENTINEL NODE BIOPSY IN CHINESE PATIENTS
  219. Prognostic Factors Affecting Survival and Recurrence of Patients with pT1 and pT2 Colorectal Cancer
  220. Obscure traumatic cardiac lesion after a penetrating chest injury: Review of the literature
  221. Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma
  222. Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization
  223. Prospective Randomized Trial on Low-pressure Versus Standard-pressure Pneumoperitoneum in Outpatient Laparoscopic Cholecystectomy
  224. Five-year experience of outpatient laparoscopic cholecystectomy in Hong Kong.
  225. Selective Portal Vein Clamping for Radiofrequency Ablation of Hepatocellular Carcinoma With Portal Vein Invasion
  226. Outpatient Laparoscopic Cholecystectomy in Hong Kong Chinese – An Outcome Analysis
  227. Management of hepatocellular carcinoma in renal transplant recipients
  228. Management of biliary anastomotic stricture in living-donor liver transplantation